source
- New acting head Karim Mikhail seeks to steady FDA’s biologics center after turbulent leadershipKarim Mikhail, the acting director of the FDA’s Center for Biologics Evaluation and Research, told staff in a town‑hall meeting that he understands the pressures they face and wants to work alongsi…
- I&I startup Attovia Therapeutics files for IPO as biotech listing wave gains paceAttovia Therapeutics, an I&I startup that develops biologics, filed a registration statement to go public on Tuesday after the market closed. The filing brings the number of biotech companies expe…